Studying and evaluating pharmaceutical policy - Becoming a part of the policy and consultative process

Pharmacy World and Science

Volumn 28, Issue 1, 2006, Pages 6-12

  Almarsdóttir, Anna Birna ^a,b   Traulsen, Janine M ^c  

^a UNIVERSITY OF ICELAND   (Iceland)

^b REYKJAVIK UNIVERSITY   (Iceland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Evaluation; Evidence; Pharmaceutical policy; Policy analysis; Research

Indexed keywords

DRUG;

ARTICLE; DRUG INDUSTRY; EVALUATION RESEARCH; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; INTERNATIONAL COOPERATION; METHODOLOGY; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS;

DRUG INDUSTRY; HEALTH POLICY; LEGISLATION, DRUG; PHARMACEUTICAL SERVICES; POLICY MAKING; REFERRAL AND CONSULTATION; RESEARCH DESIGN;

EID: 33746915708     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9011-0     Document Type: Article

References (28)

1. Traulsen JM, Almarsdóttir AB. The argument for pharmaceutical policy. Pharm World Sci 2005; 27:7-12
2. Shulock N. The paradox of policy analysis: if it is not used, why do we produce so much of it? J Pol Anal Mgt 1999; 18(2):226-244
3. Drummond M, Brown R, Fendrick AM, Fullerton P, Neumann P, Taylor R, Barbieri M. Use of pharmacoeconomics information - report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. Value Health 2003; 6(4):407-416
4. Smith F. Research methods in pharmacy practice. London: Pharmaceutical Press; 2002. p. 203-277
5. Traulsen JM, Klinke BO. Using health technology assessment to put pharmaceutical care on the political agenda. Pharm World Sci 2004; 26(2):61-63
6. Cook TD, Campbell DT. Quasi-experimentation designs and analysis issues for field settings. Boston: Houghton Mifflin Company; 1979. p. 6
7. Almarsdóttir AB, Morgall JM, Grímsson A. Cost containment of pharmaceutical use in Iceland: the impact of liberalisation and user charges. J Health Serv Res Policy 2000; 5(2):109-113
8. Almarsdóttir AB, Grímsson A. Over-the-counter codeine use in Iceland: the impact of increased access. Scand J Public Health 2000; 28:270-274
9. Morgall JM, Almarsdóttir AB. No struggle, no strength: how pharmacists lost their monopoly. Soc Sci Med 1999; 48:1247-1258
10. Almarsdóttir AB, Morgall JM. Technicians or patient advocates? - still a valid question. (results of focus group discussions with pharmacists). Pharm World Sci 1999; 21(3):127-131
11. Almarsdóttir AB, Morgall JM, Grímsson A. Professional responsibility for patient welfare. Is it possible to legislate pharmaceutical care? J Soc Admin Pharm 2001; 18(2):45-50
12. Almarsdóttir AB, Björnsdóttir I, Morgall Traulsen J. Pharmacists in a liberalised system - results from a profession-wide survey in Iceland. Int J Phar Practice 2002; 10:47-53
13. Almarsdóttir AB, Morgall JM, Björnsdóttir I. A question of emphasis: efficiency or equality in the provision of pharmaceuticals. Int J Health Plan Manage 2000; 15:149-161
14. Morgall Traulsen J, Almarsdóttir AB, Björnsdóttir I. The lay user perspective on the quality of pharmaceuticals, drug therapy, and pharmacy services. Pharm World Sci 2002; 24:4
15. Larsen JB, Mount J, Kruse PR, Vrangbæk K. Dynamics of pharmacy regulation in Denmark, 1546-1932: a study of profession-state relations. Pharm Hist 2004; 46:3-25
16. Larsen JB, Mount J, Kruse PR, Vrangbæk K. Dynamics of pharmacy regulation in Denmark, 1932-1994: a study of profession-state relations. Pharm Hist 2004; 46:3-25
17. Larsen JB, Vrangbæk K, Traulsen JM. Advocacy coalitions and pharmacy policy in Denmark: solid cores with fuzzy edges. Soc Sci Med 2006 (in press) (accepted Dec. 05)
18. Noerreslet M, Larsen JB, Traulsen JM. The medicine user - lost in translation? Analysis of the official political debate prior to the deregulation of the Danish medicine distribution system. Soc Sci Med 2005; 61:1733-1740
19. Dunn WN. Public policy analysis. Englewood Cliffs, NJ: Prentice Hall; 1981
20. Trochim WM. The research methods knowledge base. 2nd ed. Internet WWW page, at URL:〈http://www.socialresearchmethods.net/kb/〉 (version current as of August 16, 2004)
21. Patton MQ. Qualitative evaluation and research methods. 2nd ed. London: Sage Publications; 1990
22. Meyer J. Qualitative research in health care: using qualitative methods in health related action research. BMJ 2000; 320(7228):178-181
23. Pope C, Ziebland S, Mays N. Qualitative research in health care: analysing qualitative data. BMJ 2000; 320(7227):114-6
24. Mays N, Pope C. Qualitative research in health care: assessing quality in qualitative research. BMJ 2000; 320(7226):50-52
25. Hanney SR, Gonzalez-Block MA, Buxton MJ, Kogan M. They utilisation of health research in policy-making: concepts, examples, and methods of assessment - A report to the Research Policy and Co-operation Department, World Health Organization, Geneva. HERG Research Report No. 28. Uxbridge, Middlesex: Brunel University; 2002
26. Campbell DT. Reforms as experiments. Am Psychol 1969; 24:409-429
27. Davies P. Internationalisation as context for systematic reviews. Presentation at the Campbell Collaboration Colloquium, Stockholm, Sweden, February 27, 2003
28. The Cochrane Library. Pharmaceutical policies: effects on rational drug use. The Cochrane collaboration, Reprint of a Cochrane review, prepared and maintained by CC. Published in The Cochrane Library 2004, Issue 2. 2004